-
1
-
-
0031807196
-
The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7)
-
Bagheri-Yarmand R., Kourbali Y., Mabilat C., Morère J.F., Martin A., Lu H., Soria C., Jozefonvicz J. and Crépin M. (1998). The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7). Br. J. Cancer 78, 111-118.
-
(1998)
Br. J. Cancer
, vol.78
, pp. 111-118
-
-
Bagheri-Yarmand, R.1
Kourbali, Y.2
Mabilat, C.3
Morère, J.F.4
Martin, A.5
Lu, H.6
Soria, C.7
Jozefonvicz, J.8
Crépin, M.9
-
2
-
-
27744587931
-
Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene
-
Barclay C., Li A.W., Geldenhuys L., Baguma-Nibasheka M., Porter G.A., Veugelers P.J., Murphy P.R. and Casson A.G. (2005). Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene. Clin. Cancer Res. 11, 7683-7691.
-
(2005)
Clin. Cancer Res
, vol.11
, pp. 7683-7691
-
-
Barclay, C.1
Li, A.W.2
Geldenhuys, L.3
Baguma-Nibasheka, M.4
Porter, G.A.5
Veugelers, P.J.6
Murphy, P.R.7
Casson, A.G.8
-
3
-
-
79958706576
-
Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects
-
Bottino M.C., Cerliani J.P., Rojas P., Giulianelli S., Soldati R., Mondillo C., Gorostiaga M.A., Pignataro O.P., Calvo J.C., Gutkind J.S., Panomwat A., Molinolo A.A., Lüthy I.A. and Lanari C. (2011). Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effects. Breast Cancer Res. Treat. 126, 621-636.
-
(2011)
Breast Cancer Res. Treat
, vol.126
, pp. 621-636
-
-
Bottino, M.C.1
Cerliani, J.P.2
Rojas, P.3
Giulianelli, S.4
Soldati, R.5
Mondillo, C.6
Gorostiaga, M.A.7
Pignataro, O.P.8
Calvo, J.C.9
Gutkind, J.S.10
Panomwat, A.11
Molinolo, A.A.12
Lüthy, I.A.13
Lanari, C.14
-
4
-
-
36048942703
-
Aberrant fibroblast growth factor receptor signaling in bladder and other cancers
-
Chaffer C.L., Dopheide B., Savagner P., Thompson E.W. and Williams E.D. (2007). Aberrant fibroblast growth factor receptor signaling in bladder and other cancers. Differentiation 75, 831-842.
-
(2007)
Differentiation
, vol.75
, pp. 831-842
-
-
Chaffer, C.L.1
Dopheide, B.2
Savagner, P.3
Thompson, E.W.4
Williams, E.D.5
-
5
-
-
0030880344
-
Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma
-
Colomer R., Aparicio J., Montero S., Guzmán C., Larrodera L. and Cortés-Funes H. (1997). Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma. Br. J. Cancer 76, 1215-1220.
-
(1997)
Br. J. Cancer
, vol.76
, pp. 1215-1220
-
-
Colomer, R.1
Aparicio, J.2
Montero, S.3
Guzmán, C.4
Larrodera, L.5
Cortés-Funes, H.6
-
6
-
-
0036175799
-
Long-term follow-up and prognostic significance of angiogenic basic fibroblast growth factor (bFGF) expression in patients with breast cancer
-
Faridi A., Rudlowski C., Biesterfeld S., Schuh S., Rath W. and Schröder W. (2002). Long-term follow-up and prognostic significance of angiogenic basic fibroblast growth factor (bFGF) expression in patients with breast cancer. Pathol. Res. Pract. 198, 1-5.
-
(2002)
Pathol. Res. Pract
, vol.198
, pp. 1-5
-
-
Faridi, A.1
Rudlowski, C.2
Biesterfeld, S.3
Schuh, S.4
Rath, W.5
Schröder, W.6
-
7
-
-
78751488034
-
MCF-7 cell apoptosis and cell cycle arrest: Non-genomic effects of progesterone and mifepristone (RU-486)
-
Fjelldal R., Moe B.T., Ørbo A. and Sager G. (2010). MCF-7 cell apoptosis and cell cycle arrest: non-genomic effects of progesterone and mifepristone (RU-486). Anticancer Res. 30, 4835-40.
-
(2010)
Anticancer Res
, vol.30
, pp. 4835-4840
-
-
Fjelldal, R.1
Moe, B.T.2
ørbo, A.3
Sager, G.4
-
8
-
-
57349113716
-
Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis
-
Giulianelli S., Cerliani J.P., Lamb C.A., Fabris V.T., Bottino M.C., Gorostiaga M.A., Novaro V., Góngora A., Baldi A., Molinolo A. and Lanari C. (2008). Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis. Int. J. Cancer 123, 2518-2531.
-
(2008)
Int. J. Cancer
, vol.123
, pp. 2518-2531
-
-
Giulianelli, S.1
Cerliani, J.P.2
Lamb, C.A.3
Fabris, V.T.4
Bottino, M.C.5
Gorostiaga, M.A.6
Novaro, V.7
Góngora, A.8
Baldi, A.9
Molinolo, A.10
Lanari, C.11
-
9
-
-
85010755483
-
Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: Useful as diagnostic tools?
-
Granato A.M., Nanni O., Falcini F., Folli S., Mosconi G., De Paola F., Medri L., Amadori D. and Volpi A. (2004). Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools? Breast Cancer Res. 6, R38-45.
-
(2004)
Breast Cancer Res
, vol.6
-
-
Granato, A.M.1
Nanni, O.2
Falcini, F.3
Folli, S.4
Mosconi, G.5
de Paola, F.6
Medri, L.7
Amadori, D.8
Volpi, A.9
-
10
-
-
0034107392
-
Progression in MCF-7 breast cancer cell tumorigenicity: Compared effect of FGF-3 and FGF-4
-
Hajitou A., Deroanne C., Noël A., Collette J., Nusgens B., Foidart J.M. and Calberg-Bacq C.M. (2000). Progression in MCF-7 breast cancer cell tumorigenicity: compared effect of FGF-3 and FGF-4. Breast Cancer Res. Treat. 60, 15-28.
-
(2000)
Breast Cancer Res. Treat
, vol.60
, pp. 15-28
-
-
Hajitou, A.1
Deroanne, C.2
Noël, A.3
Collette, J.4
Nusgens, B.5
Foidart, J.M.6
Calberg-Bacq, C.M.7
-
11
-
-
0032005986
-
Progestin regulation of vascular endothelial growth factor in human breast cancer cells
-
Hyder S.M., Murthy L. and Stancel G.M. (1998). Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer Res. 58, 392-395.
-
(1998)
Cancer Res
, vol.58
, pp. 392-395
-
-
Hyder, S.M.1
Murthy, L.2
Stancel, G.M.3
-
12
-
-
0035874047
-
Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells
-
Hyder S.M., Chiappetta C. and Stancel G.M. (2001). Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells. Int. J. Cancer 92, 469-473.
-
(2001)
Int. J. Cancer
, vol.92
, pp. 469-473
-
-
Hyder, S.M.1
Chiappetta, C.2
Stancel, G.M.3
-
13
-
-
78349246291
-
Mammary gland growth factors: Roles in normal development and in cancer
-
Hynes N.E. and Watson C.J. (2010). Mammary gland growth factors: roles in normal development and in cancer. Cold Spring Harb. Perspect. Biol. 2:a003186.
-
(2010)
Cold Spring Harb. Perspect. Biol
, vol.2
-
-
Hynes, N.E.1
Watson, C.J.2
-
14
-
-
33750336566
-
The effect of progesterone, Testosterone and synthetic progestogens on growth factor-and estradiol-treated human cancerous and benign breast cells
-
Krämer E.A., Seeger H., Krämer B., Wallwiener D. and Mueck A.O. (2006). The effect of progesterone, Testosterone and synthetic progestogens on growth factor-and estradiol-treated human cancerous and benign breast cells. Eur. J. Obstet. Gynecol. Reprod. Biol. 129, 77-83.
-
(2006)
Eur. J. Obstet. Gynecol. Reprod. Biol
, vol.129
, pp. 77-83
-
-
Krämer, E.A.1
Seeger, H.2
Krämer, B.3
Wallwiener, D.4
Mueck, A.O.5
-
15
-
-
1642344519
-
Suppression of tumor growth and angiogenesis in vivo by a truncated form of 24-kd fibroblast growth factor (FGF)-2
-
Levin E.G., Sikora L., Ding L., Rao S.P. and Sriramarao P. (2004). Suppression of tumor growth and angiogenesis in vivo by a truncated form of 24-kd fibroblast growth factor (FGF)-2. Am. J. Pathol. 164,1183-1190.
-
(2004)
Am. J. Pathol
, vol.164
, pp. 1183-1190
-
-
Levin, E.G.1
Sikora, L.2
Ding, L.3
Rao, S.P.4
Sriramarao, P.5
-
16
-
-
35448981411
-
Progestin-dependent progression of human breast tumor xenografts: A novel model for evaluating antitumor therapeutics
-
Liang Y., Besch-Williford C., Brekken R.A. and Hyder S.M. (2007). Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics. Cancer Res. 67, 9929-9936.
-
(2007)
Cancer Res
, vol.67
, pp. 9929-9936
-
-
Liang, Y.1
Besch-Williford, C.2
Brekken, R.A.3
Hyder, S.M.4
-
17
-
-
77957723055
-
Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice
-
Liang Y., Benakanakere I., Besch-Williford C., Hyder R.S., Ellersieck M.R. and Hyder S.M. (2010). Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude mice. Menopause 17, 1040-1047.
-
(2010)
Menopause
, vol.17
, pp. 1040-1047
-
-
Liang, Y.1
Benakanakere, I.2
Besch-Williford, C.3
Hyder, R.S.4
Ellersieck, M.R.5
Hyder, S.M.6
-
18
-
-
0026696081
-
Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues
-
Luqmani Y.A., Graham M. and Coombes R.C. (1992). Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. Br. J. Cancer 66, 273-280.
-
(1992)
Br. J. Cancer
, vol.66
, pp. 273-280
-
-
Luqmani, Y.A.1
Graham, M.2
Coombes, R.C.3
-
19
-
-
0032720654
-
Overexpression of basic fibroblast growth factor (FGF-2) downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells
-
Maloof P., Wang Q., Wang H., Stein D., Denny T.N., Yahalom J., Fenig E. and Wieder R. (1999). Overexpression of basic fibroblast growth factor (FGF-2) downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res. Treat. 56, 153-67.
-
(1999)
Breast Cancer Res. Treat
, vol.56
, pp. 153-167
-
-
Maloof, P.1
Wang, Q.2
Wang, H.3
Stein, D.4
Denny, T.N.5
Yahalom, J.6
Fenig, E.7
Wieder, R.8
-
20
-
-
0033611570
-
Increased expression of fibroblast growth factor 8 in human breast cancer
-
Marsh S.K., Bansal G.S., Zammit C., Barnard R., Coope R., Roberts-Clarke D., Gomm J.J., Coombes R.C. and Johnston C.L. (1999). Increased expression of fibroblast growth factor 8 in human breast cancer. Oncogene 18, 1053-1060.
-
(1999)
Oncogene
, vol.18
, pp. 1053-1060
-
-
Marsh, S.K.1
Bansal, G.S.2
Zammit, C.3
Barnard, R.4
Coope, R.5
Roberts-Clarke, D.6
Gomm, J.J.7
Coombes, R.C.8
Johnston, C.L.9
-
21
-
-
0025053671
-
Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor
-
Meyer M.E., Pornon A., Ji J.W., Bocquel M.T., Chambon P. and Gronemeyer H. (1990). Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor. EMBO J. 9, 3923-3932.
-
(1990)
EMBO J
, vol.9
, pp. 3923-3932
-
-
Meyer, M.E.1
Pornon, A.2
Ji, J.W.3
Bocquel, M.T.4
Chambon, P.5
Gronemeyer, H.6
-
22
-
-
0035081241
-
Fibroblast growth factors
-
Ornitz D.M. and Itoh N. (2001). Fibroblast growth factors. Genome Biol. 2, 1-12.
-
(2001)
Genome Biol
, vol.2
, pp. 1-12
-
-
Ornitz, D.M.1
Itoh, N.2
-
23
-
-
15844368097
-
Receptor specificity of the fibroblast growth factor family
-
Ornitz D.M., Xu J., Colvin J.S., McEwen D.G., MacArthur C.A., Coulier F., Gao G. and Goldfarb M. (1996). Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271, 15292-15297.
-
(1996)
J. Biol. Chem
, vol.271
, pp. 15292-15297
-
-
Ornitz, D.M.1
Xu, J.2
Colvin, J.S.3
McEwen, D.G.4
Macarthur, C.A.5
Coulier, F.6
Gao, G.7
Goldfarb, M.8
-
24
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial
-
Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M. and Ockene J. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333.
-
(2002)
JAMA
, vol.288
, pp. 321-333
-
-
Rossouw, J.E.1
Anderson, G.L.2
Prentice, R.L.3
Lacroix, A.Z.4
Kooperberg, C.5
Stefanick, M.L.6
Jackson, R.D.7
Beresford, S.A.8
Howard, B.V.9
Johnson, K.C.10
Kotchen, J.M.11
Ockene, J.12
-
25
-
-
0035872484
-
Enhanced invasion and tumor growth of fibroblast growth factor 8boverexpressing MCF-7 human breast cancer cells
-
Ruohola J.K., Viitanen T.P., Valve E.M., Seppänen J.A., Loponen N.T., Keskitalo J.J., Lakkakorpi P.T. and Härkönen P.L. (2001). Enhanced invasion and tumor growth of fibroblast growth factor 8boverexpressing MCF-7 human breast cancer cells. Cancer Res. 61, 4229-4237.
-
(2001)
Cancer Res
, vol.61
, pp. 4229-4237
-
-
Ruohola, J.K.1
Viitanen, T.P.2
Valve, E.M.3
Seppänen, J.A.4
Loponen, N.T.5
Keskitalo, J.J.6
Lakkakorpi, P.T.7
Härkönen, P.L.8
-
26
-
-
0030011512
-
Aberrant FGF-2, FGF-3, FGF-4 and C-erb-B2 gene copy number in human ovarian, breast and endometrial tumours
-
Schmitt J.F., Susil B.J. and Hearn M.T. (1996). Aberrant FGF-2, FGF-3, FGF-4 and C-erb-B2 gene copy number in human ovarian, breast and endometrial tumours. Growth Factors 13, 19-35.
-
(1996)
Growth Factors
, vol.13
, pp. 19-35
-
-
Schmitt, J.F.1
Susil, B.J.2
Hearn, M.T.3
-
27
-
-
70249146546
-
Fibroblast growth factors in development and cancer: Insights from the mammary and prostate glands
-
Schwertfeger K.L. (2009). Fibroblast growth factors in development and cancer: insights from the mammary and prostate glands. Curr. Drug Targets 10, 632-44.
-
(2009)
Curr. Drug Targets
, vol.10
, pp. 632-644
-
-
Schwertfeger, K.L.1
-
28
-
-
34547662090
-
Basic FGF augments hypoxia induced HIF-1-alpha expression and VEGF release in T47D breast cancer cells
-
Shi Y.H., Bingle L., Gong L.H., Wang Y.X., Corke K.P. and Fang W.G. (2007). Basic FGF augments hypoxia induced HIF-1-alpha expression and VEGF release in T47D breast cancer cells. Pathology 39, 396-400.
-
(2007)
Pathology
, vol.39
, pp. 396-400
-
-
Shi, Y.H.1
Bingle, L.2
Gong, L.H.3
Wang, Y.X.4
Corke, K.P.5
Fang, W.G.6
-
29
-
-
15444349656
-
High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8
-
Tanaka A., Furuya A., Yamasaki M., Hanai N., Kuriki K., Kamiakito T., Kobayashi Y., Yoshida H., Koike M. and Fukayama M. (1998). High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8. Cancer Res. 58, 2053-2056.
-
(1998)
Cancer Res
, vol.58
, pp. 2053-2056
-
-
Tanaka, A.1
Furuya, A.2
Yamasaki, M.3
Hanai, N.4
Kuriki, K.5
Kamiakito, T.6
Kobayashi, Y.7
Yoshida, H.8
Koike, M.9
Fukayama, M.10
-
30
-
-
0024405510
-
Amplification of FGF-related genes in human tumors: Possible involvement of HST in breast carcinomas
-
Theillet C., Le Roy X., De Lapeyrière O., Grosgeorges J., Adnane J., Raynaud S.D., Simony-Lafontaine J., Goldfarb M., Escot C. and Birnbaum D. (1989). Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas. Oncogene 4, 915-922.
-
(1989)
Oncogene
, vol.4
, pp. 915-922
-
-
Theillet, C.1
Le Roy, X.2
de Lapeyrière, O.3
Grosgeorges, J.4
Adnane, J.5
Raynaud, S.D.6
Simony-Lafontaine, J.7
Goldfarb, M.8
Escot, C.9
Birnbaum, D.10
-
31
-
-
0029757966
-
16·-substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity
-
Wagner B.L., Pollio G., Leonhardt S., Lee D.Y.W., Imhof M.O., Edwards D.P., Cook C.E. and McDonnell D.P. (1996). 16·-substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity. Pharmacology 93, 8739-8744
-
(1996)
Pharmacology
, vol.93
, pp. 8739-8744
-
-
Wagner, B.L.1
Pollio, G.2
Leonhardt, S.3
Lee, D.Y.W.4
Imhof, M.O.5
Edwards, D.P.6
Cook, C.E.7
McDonnell, D.P.8
-
32
-
-
0031021337
-
Fibroblast growth factor 2 in breast cancer: Occurrence and prognostic significance
-
Yiangou C., Gomm J.J., Coope R.C., Law M., Luqmani Y.A., Shousha S., Coombes R.C. and Johnston C.L. (1997). Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance. Br. J. Cancer 75, 28-33.
-
(1997)
Br. J. Cancer
, vol.75
, pp. 28-33
-
-
Yiangou, C.1
Gomm, J.J.2
Coope, R.C.3
Law, M.4
Luqmani, Y.A.5
Shousha, S.6
Coombes, R.C.7
Johnston, C.L.8
-
33
-
-
85047698654
-
Fibroblast growth factor 8 is expressed at higher levels in lactating human breast and in breast cancer
-
Zammit C., Coope R., Gomm J.J., Shousha S., Johnston C.L. and Coombes R.C. (2002). Fibroblast growth factor 8 is expressed at higher levels in lactating human breast and in breast cancer. Br. J. Cancer 86, 1097-1103.
-
(2002)
Br. J. Cancer
, vol.86
, pp. 1097-1103
-
-
Zammit, C.1
Coope, R.2
Gomm, J.J.3
Shousha, S.4
Johnston, C.L.5
Coombes, R.C.6
-
34
-
-
33744937606
-
Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family
-
Zhang X., Ibrahimi O.A., Olsen S.K., Umemori H., Mohammadi M. and Ornitz D.M. (2006). Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J. Biol. Chem. 281, 15694-15700.
-
(2006)
J. Biol. Chem
, vol.281
, pp. 15694-15700
-
-
Zhang, X.1
Ibrahimi, O.A.2
Olsen, S.K.3
Umemori, H.4
Mohammadi, M.5
Ornitz, D.M.6
|